We recently published 12 Stocks on Jim Cramer’s Radar. McKesson Corporation (NYSE:MCK) is one of the stocks on Jim Cramer’s radar.
McKesson Corporation (NYSE:MCK) is one of the largest healthcare services providers in America. Its shares are up by 59% over the past year and by 15% year-to-date. Several analysts have discussed McKesson Corporation (NYSE:MCK) in 2026. For instance, TD Cowen raised the share price target to $1,012 from $1,000 and kept a Buy rating on the shares in February. The coverage followed McKesson Corporation (NYSE:MCK)’s latest earnings report. TD Cowen commented that the firm’s pharmaceutical and cancer businesses were performing well and added that it had performed well in the earnings despite high expectations. Before the earnings, Morgan Stanley raised the share price target to $966 from $916 and kept an Overweight rating on the shares. McKesson Corporation (NYSE:MCK)’s cancer business also played a role in Morgan Stanley’s optimism. As for Cramer, the CNBC TV host has recently started discussing the firm along with President Trump:
20 Countries with the Most Expensive Healthcare in the World
“But do I want to point out the middleman where there’s no rest. The middleman. McKesson today, leading the S&P. This is a company that the President, it’s in his crosshairs, he has failed. They are more powerful than President Trump.”
While we acknowledge the potential of MCK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
